In a phase 2 trial published in The New England Journal of Medicine , retatrutide produced substantial weight loss in adults with obesity or overweight over 48 weeks, with the highest-dose groups achieving reductions that reached up to 24.2%
Its main effect is reducing deep visceral fat, so your waist can shrink while total weight changes only a little
No serious adverse events took place
By leveraging advancements in genomics and molecular diagnostics, personalized approaches can identify unique patient profiles, allowing for the selection of targeted therapies that align with the specific biological mechanisms driving disease in each patient [88]
Nat Rev Immunol 10:131144
The two higher doses will be priced at $299 for a months supply, while the 4 mg dose will rise to $199 from April 15, the drugmakers website shows